|
市場調查報告書
全球鼠疫(耶爾森氏菌)診斷市場:成長機會及產業擴張策略
Global Yersinia Diagnostics Market: Growth Opportuinites and Business Expansion Strategies
|
全球鼠疫(耶爾森氏菌)診斷市場:成長機會及產業擴張策略 是由出版商Venture Planning Group在2011年11月所出版的。
這份英文市場調查報告書價格從美金3850起跳。
本報告提供全球主要國家(美國、英國、德國、法國、義大利、西班牙、日本)的鼠疫(耶爾森氏菌)診斷市場相關調查分析，鼠疫(耶爾森氏菌)定義、免疫學、病因，及診斷檢驗技術的最新趨勢，今後5∼10年的各國的市場趨勢(市場規模、銷售額、市場佔有率等)，今後的市場發展策略和障礙，各企業簡介等資訊彙整，為您概述為以下內容。
第1章 簡介
第2章 全球市場及技術概要
- 背景情況
- 診斷檢驗
- 疫苗及藥物
- 新的診斷技術
- (DNA)核酸探針
- 單株抗體
- 免疫分析
- 光散射分析
- 微電腦、自動化
- 人工智能
- 微脂體
- 流式細胞技術
- 色譜儀
- MRI
- 凝膠微滴法
- 其他
第3章 法國市場:市場規模，成長，主要業者的銷售額與市場佔有率
第4章 德國市場:市場規模，成長，主要業者的銷售額與市場佔有率
第5章 義大利市場:市場規模，成長，主要業者的銷售額與市場佔有率
第6章 日本市場:市場規模，成長，主要業者的銷售額與市場佔有率
第7章 西班牙市場:市場規模，成長，主要業者的銷售額與市場佔有率
第8章 英國市場:市場規模，成長，主要業者的銷售額與市場佔有率
第9章 美國市場:市場規模，成長，主要業者的銷售額與市場佔有率
第10章 替代性的打入市場策略
- 內部開發
- 合資企業協定
- 與大學的契約
- 分散檢驗市場流通策略
- 行銷的方法
- 產品的複雜性
- 客戶的偏好
- 現有的供應商
- 新加入廠商供應商
- 主要種類的流通業者
- 市場分類
第11章 加入市場的潛在障礙與風險
- 市場的成熟度
- 成本控制
- 競爭
- 技術的限制
- 專利保護
- 法規限制
- 分散檢驗市場課題
第12章 競爭企業分析
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- BioRad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- 第一三共
- DiaSorin
- Diagast
- Diamedix
- Digene
- 榮研化學
- Enzo Biochem
- 富士Rebio
- GenBio
- GeneTec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- 日水製藥
- Olympus Corporation
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosoh
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
圖表一覽
Abstract
The report presents a detailed analysis of the Yersinia diagnostics market in
the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current
scientific views on the Yersinia definition, epidemiology and etiology are
reviewed.
The report provides the 5- and 10-year test volume and sales forecasts by
country for the following market segments:
- Hospitals
- Commercial/Private Labs
- Physician Offices
- Public Health Labs
Also, the report examines the market applications of DNA Probes, Monoclonal
Antibodies, Immunoassays, IT and other technologies; profiles leading
suppliers and recent market entrants developing innovative technologies and
products; and identifies emerging business expansion opportunities,
alternative market penetration strategies, market entry barriers and risks,
and strategic planning issues and concerns.
Contains: : 197 pages and 8 tables.
Table of Contents
I. Introduction
II. Worldwide Market and Technology Overview
- A. Background
- B. Diagnostic Tests
- C. Vaccines and Drugs
- D. Emerging Diagnostic Technologies
- 1. DNA Probes
- a. Technology Overview
- b. Amplification Methods
- Polymerase Chain Reaction
- Robotics
- Temperature Cyclers
- PCR Variations
- Immuno-PCR
- QC-PCR
- DAP-PCR
- Ligase Chain Reaction
- Branched DNA
- Q-Beta Replicase
- Nucleic-Acid Sequence-Based
- Strand Displacement Activation
- Self-Sustained Sequence Replicase
- 2. Monoclonal Antibodies
- 3. Immunoassays
- a. Technological Principle
- b. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- Dot Immunobinding Assays
- Capillary Immunoassays
- Particle-Membrane Capture Immunoassays
- Enzyme Amplification
- c. Fluorescent Immunoassays
- Fluorescence Polarization
- Time-Resolved Pulse Fluorescence
- d. Luminescence
- Chemiluminescence
- Bioluminescence
- e. Latex Agglutination
- f. Immunoprecipitation
- 4. Differential Light Scattering
- 5. Microcomputers and Automation
- 6. Artificial Intelligence
- 7. Liposomes
- 8. Flow Cytometry
- 9. Chromatography
- 10. MRI
- 11. Gel Microdroplets
- 12. Other
III. France: Test Volume and Diagnostics Sales Forecast by Market Segment
IV. Germany: Test Volume and Diagnostics Sales Forecast by Market Segment
V. Italy: Test Volume and Diagnostics Sales Forecast by Market Segment
VI. Japan: Test Volume and Diagnostics Sales Forecast by Market Segment
VII. Spain: Test Volume and Diagnostics Sales Forecast by Market Segment
VIII. UK: Test Volume and Diagnostics Sales Forecast by Market Segment
IX. USA: Test Volume and Diagnostics Sales Forecast by Market Segment
X. Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative Arrangements
- C. University Contracts
- D. Distribution Strategies for Decentralized Testing Markets
- 1. Marketing Approaches
- 2. Product Complexity
- 3. Customer Preference
- 4. Established Suppliers
- 5. Emerging Suppliers
- 6. Major Types of Distributors
- 7. Market Segmentation
XI. Potential Market Entry Barriers and Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge and Limitations
- E. Patent Protection
- F. Regulatory Constraints
- G. Decentralized Testing Market Challenges
XII. Competitive Assessments
- Abbott
- Affymetrix
- Applera
- Beckman Coulter
- Becton Dickinson
- Binding Site
- Biomerica
- Biokit
- bioMerieux
- Bio-Rad
- Biotrol
- Biosite
- Biotest
- Caliper Technologies
- Cepheid
- Chemicon
- Daiichi
- DiaSorin
- Diagast
- Diamedix
- Digene
- Eiken
- Enzo Biochem
- Fujirebio
- GenBio
- Gene-Tec
- Hemagen
- Immunetics
- Innogenetics
- Inverness
- J&J
- Meridian
- Nanogen
- Nissui
- Olympus
- Provalis
- Roche
- Saliva Diagnostic
- SeraCare
- Siemens
- Third Wave Technologies
- Thermo Fisher
- Tosho
- Trinity Biotech
- Tropix
- Wampole Labs
- Zenith
- Zeus
List of Tables
- Major Companies Developing or Marketing Yersinia Tests
- France
- Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
- Germany
- Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
- Italy
- Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
- Japan
- Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
- Spain
- Yersinia Test Volume Amd Diagnostics Sales Forecast by Market Segment
- U.K.
- Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
- U.S.A.
- Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
|
